OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-09-01-accounts

Peaches Womb Cancer Trust Annual Report and Accounts 2023-2024

Registered Charity Number: 1190440

1

Index

Contents Page Number
Trustees Report
 3
Achievements this year 7
Financial Review 13
Plans for Future Periods 13
Independent Examiner’s Report 16
Statement of Financial Activities 17
Balance Sheet 18
Notes to the Accounts 19
Appendices

  1. Background to the charity

  2. Biographies of Trustees, Staff and Key Volunteers

2

Trustees’ Report 2023-2024

The Trustees present their annual report and financial statements of the charity for the year ended 31[st] August 2024.

The financial statements comply with the Charities Act 2011 and the Accounting and Reporting by Charities Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and the Republic of Ireland (FRS 102) effective 1[st] January 2019.

Reference and administrative information

Charity Name: Peaches Womb Cancer Trust

Charity Number: 1190440

Peaches Womb Cancer Trust is an independent charitable trust.

Trustees

The trustees and officers serving during the year and since the year end were as follows:

Senior managers

3

Registered Office

Clarke Nicklin House, 4 Brooks Drive, Cheadle Royal Business Park, Cheadle, Cheshire, SK8 3TD

Independent Examiners: Clarke Nicklin Clarke Nicklin House 4 Brooks Drive Cheadle Royal Business Park Cheadle Cheshire SK8 3TD

Solicitors:

Addleshaw Goddard LLP Milton Gate 60 Chiswell Street London EC1Y 4AG

Bankers: CAF Bank 25 Kings Hill Avenue Kings Hill West Malling Kent ME19 4JQ

www.peachestrust.org Email: admin@peachestrust.org

4

Structure, Governance and Management

Peaches Womb Cancer Trust is a Charitable Incorporated Organisation (CIO), registered with the Charity Commission no: 1190440. It was established on 16[th] July 2020 and officially launched on 1[st] September 2020. This is the third set of accounts the charity has prepared, and this set of accounts covers the period from 1[st] September 2023 to 31[st] August 2024.

Management Structure

The charity is run by a Board of 8 Trustees, 5 of whom founded Peaches Womb Cancer Trust.

The Board of Trustees administers the charity. The board normally meets bi-monthly and is responsible for the strategic direction and policy of the charity. The trustees are drawn from a variety of professional backgrounds with expertise and skills relevant to the work of the charity. The Chief Executive Officer/Operations Executive is responsible for working with the Board of Trustees to formulate the strategic direction of the charity and for the day to day operations of the charity with the assistance of paid staff and volunteers. The Chief Executive Officer/Operations Executive is responsible for ensuring that the charity delivers the specified services and that key performance indicators are met and reported to the board.

Trustee induction and training

New trustees are given a Trustee Information Pack which covers:

This is distributed to all new trustees along with the organisation’s governing document.

5

Charitable Objectives

The objectives, as set out in the governing document are:

“To relieve sickness and to preserve the health and improve the experience of women with or at risk of womb cancer and their families in the United Kingdom, in particular but not exclusively by; carrying out research, raising awareness and the provision of patient education and support services.”

From 1[st] April 2018, the Charities Act requires that all charities ensure they meet their charitable objectives and that these are for the public benefit. The Charity Commission in its “Charities and Public Benefit” Guidance states that there are two key principles that must be met:

  1. There must be an identifiable benefit

  2. The benefit must be for the public or a section of the public.

The Trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake. The Trustees are satisfied that the aims and objectives of the charity and the activities reported on in this Annual Report meet these principles.

6

Activities and Achievements

2023-24 has been a key year of achievements and development for Peaches Womb Cancer Trust. We have been innovative, creative and flexible. We have spent time on developing our organisational strategy and have been excited to start to implement plans to ensure that we are the sustainable, trusted and focused organisation that we want to be- and that women with, or at risk from, womb cancer need us to be.

Awareness

A YouGov survey undertaken in 2023 highlighted that 1 in 3 people in the UK were not aware of womb cancer. This was a real call to action for Peaches, and in September 2023, we collaborated with GSK and The Eve Appeal on ‘Spot Check’, a 12-day campaign which focused on raising awareness of the disease.

The campaign targeted all women from 18 years of age and focused on the most common signs and symptoms. We used various avenues to distribute the message including a press release to national media, organic social media originating from Peaches and The Eve Appeal accounts, paid for social media advertisements and external advertising. We also used posters that were placed on the back of toilet doors in service stations across England which pointed to a microsite.

We were delighted that the campaign received social media support from ‘influencer’ doctors; Dr Aziza Sesay (29k followers) and Dr Nighat Arif (75k followers). Each made videos highlighting the signs and symptoms of womb cancer. Dr Nighat also cocreated and published a feature article on GP Online, outlining how GP practices can better support patients with gynecological concerns.

7

There were over 13 million opportunities to see the campaign messaging and significant coverage in national and local press – a positive first step in increasing the general public’s awareness of womb cancer.

Womb Cancer Awareness Month, June 2024

The absence of knowledge regarding signs and symptoms of womb cancer was highlighted once again in a survey conducted by Peaches in 2024. Womb Cancer awareness month is a valuable opportunity to talk about our work and mission, and throughout this month we shared awareness raising materials across social media featuring some of the frequently asked questions sent to our support volunteer, alongside personal experiences included in Peaches’ case studies.

Peaches also joined with the International Gynecological Cancer Society in their global campaign: Uterine (Womb) Cancer Awareness Month. This was the second year of the initiative and included 32 partners working together over the month. Social media was directed to the Uterine Cancer Awareness Month website and traffic increased by 317.4% over the period.

British Gynaecological Cancer Society Annual Scientific Meeting, July 2024

Anne and Helen W, two of our expert volunteers, represented Peaches at the Annual Scientific Meeting of the British Gynaecological Cancer Society (BGCS) in Liverpool. Our exhibition stand attracted significant interest from healthcare professionals involved in treating and supporting individuals with womb cancer, increasing awareness of our organisation within this important community. The meeting also provided an excellent opportunity to network with other gynaecological charities, researchers, clinicians, and pharmaceutical companies. A further outcome was the invitation for Peaches to participate in the Nottingham CNS Gynaecological Cancer Open Day at Maggie’s Cancer Centre which we were delighted to attend.

Website and social media

This year, we have taken important steps to update our website, after recognizing the need to improve accessibility and navigation if visitors were to easily find the information they need. The site now regularly has more than 1,000 visitors a month. In addition to this, we relaunched our newsletter in June, updating our subscribers with the latest news and signposting to the website for more information. http://peachestrust.org/

8

We were delighted to see return on our investment in marketing and communications, as illustrated by a steady increase in our Peaches social media followers. We currently have more than 3,000 accounts following Peaches across various platforms. Find us on Facebook Instagram X LinkedIn

GatewayC GP education package

Peaches are passionate about increasing the early diagnosis of womb cancer. It is critical that primary care professionals have the necessary knowledge and confidence to recognise symptoms and make referrals as required. GatewayC is an online early cancer diagnosis resource for GPs, clinicians and students. Dr Helena O’Flynn, Peaches trustee, provided clinical input and expertise to their endometrial cancer e-learning content and we are proud to be referenced in this resource.

Support for those living with and beyond womb cancer

We believe that we have a key role to play in supporting people after their diagnosis of womb cancer, empowering and informing them as they progress along their pathway. We remain committed to providing valuable, patient-centred resources for those affected by womb cancer.

Peer support is key for many, and our monthly online Peaches coffee mornings are a successful way to deliver this. The coffee mornings aim to provide a safe space for those affected by womb cancer and create an opportunity to meet others with similar experiences, to talk and listen, and to share stories and tips. Each meeting is different and is driven by the attendees and the items they would like to discuss. This year the coffee mornings have been oversubscribed and we have seen over 130 attendees. Considerable thanks go to Anne, Peaches’ volunteer and Clinical Nurse Specialist in Gynaecological Oncology for facilitating these meet ups as well as all those who dial in and make these events what they are.

We know that it is also helpful to have accessible information available at a time that suits the individual. This year, we have made significant progress on our series of patient-centred videos, designed to support people with womb cancer at various

9

stages of their journey. This project was possible thanks to a generous grant from GlaxoSmithKline (GSK) and the production support of COUCH Health. The videos provide accessible information about womb cancer diagnosis, treatment and followup. Thanks go to Anna, Anne, Debby, Marie, and Sarah for generously sharing their personal stories on camera, to those members of our community who gave input and feedback throughout the process, from reviewing storyboards to helping create accompanying materials. We also thank Helen, Anne, Dr Chloe Barr, and Prof. Emma Crosbie for their valuable contributions during pre-production and filming.

Promoting research

Peaches Patient Voices

Peaches Patient Voices (PPV) has continued to connect individuals affected by womb cancer with researchers to ensure that their research aligns with the priorities of patients and their families, ultimately improving outcomes for those living with and beyond womb cancer. This is crucial and impactful work. Over the past year, we welcomed nine new members to PPV, and its members have actively contributed to shaping four UK-led research projects. We were also excited to highlight the benefits of joining PPV when our lead, Helen White, and long-standing member, Danni Elster, recorded an episode of the Research Adjacent podcast. You can listen to it here.

Over the year, PPV has provided several letters of support for various research grant applications and we are thrilled that one of these (focused on how health services can better support individuals with gynaecological cancer in making informed decisions about radiotherapy) has been awarded a grant by the National Institute for Health and Care Research (NIHR). Our vice-chair has been invited to serve on the study's steering committee and PPV members will join the public and patient involvement group once the study begins.

Two PPV members were selected to share their experiences of developing womb cancer symptoms before menopause with the aforementioned GatewayC. Their valuable insights were incorporated into the e-learning course on womb cancer supporting awareness of early diagnosis of womb cancer in younger women.

Furthermore, Helen W, PPV lead represented us as one of four patient advocates from around the world at the Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Research, and co-authored the resulting paper: Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup (2024).

10

Advocating for those affected by womb cancer

Peaches contributed to the National Institute for Health and Care Excellence (NICE) appraisal of dostarlimab (an immunotherapy drug used in combination with chemotherapy for advanced or recurrent womb cancer). In March 2024, we were thrilled to learn that it had been recommended through the Cancer Drugs Fund. This was quickly followed by the acceptance of the treatment by the Scottish Medicines Consortium (SMC), ensuring that this innovative first-line option is now available to many patients throughout the UK.

Following NICE’s announcement, NHS England featured the decision in a news story. Peaches Patient Voices (PPV) member, Sue, was interviewed live by Dan Walker on Channel 5 News, appeared in a segment on ITV Border, as well as being featured in The Independent, The Sun and The Mirror and on social media platforms. This widespread coverage helped share the positive news regarding this new womb cancer treatment with a broad audience across the UK and beyond. Sue’s lived experience was so valuable in adding context to this news. We are thankful to her for sharing her story in this way.

The successful outcomes of these appraisals would not have been possible without the invaluable contributions of PPV members. The powerful testimonies and lived experiences shared by them played a crucial role in informing our evidence submissions and provided valuable input to the NICE and SMC committees’ decisionmaking processes.

Fundraising and Income Generation

Peaches fundraising events

Twenty-seven people are diagnosed with womb cancer every day in the UK. In line with this statistic, we trialed a new Peaches fundraiser in January 2024. In ‘2 for 27’, we asked supporters to raise funds for Peaches by walking 2 miles every day for 27 days in January. While sign up was lower than we had hoped for, those who did participate were truly engaged, supported each other brilliantly and raised more than the anticipated fundraising per person. This experience has provided valuable learning for our future events.

We updated our “Peaches and Cream Tea” off the shelf activity to align with our updated branding. A volunteer for Peaches flew the flag again this year with an incredible fundraising event raising over £2500.

11

Charity of the Year Partnership

We are grateful to the ladies at the Whittington Golf Club, especially their Captain Anne Tracey, who chose Peaches as their Charity of the Year. The Club raised more than £8,000 from their events, including taking on the Thames Path challenge.

In memory donations

We have partnered with Much Loved this year. This online platform allows us to provide a dedicated space for those who have lost loved ones to womb cancer. Friends, family and colleagues can pay their respects and share memories on the Much Loved tributes, and make a donation to Peaches in their memory, should they wish to do so.

Grant funding

Thanks to players of People's Postcode Lottery, Peaches were awarded £10,000 by the Postcode Neighbourhood Trust. We are grateful for this grant which has helped us to achieve our charitable aims through funding core costs and supporting our ongoing development.

Fundraising by Peaches’ supporters

Our community of supporters and fundraisers continues to be innovative, creative, dedicated and engaged with our organisation. Over this financial year, our community fundraisers have generated more invaluable unrestricted income for us than ever, exceeding last year’s total. These funds may come from a one-off walk, danceathon, first-time marathon or bake sale or they may be generated from a more sustained and varied campaign, such as that organised and facilitated by Bev Playle and her friends and family, whose fundraising efforts have brought in more than £10,000 to support our work.

We are so appreciative of every pound that comes to our charity through those who have benefitted from our support. We could not undertake our work without the generous donations and hard work of our supporters. We would like to say a massive thank you to all who have held events, challenged themselves and donated.

Thank you to everyone who has supported Peaches, in any way over the last year, particularly those who, despite living with or beyond womb cancer, have raised money for us. Without your support, we . would not be where we are today

12

Financial Review

The accounts have been prepared in accordance with the accounting policies set out in note 1 to the accounts and comply with the charity’s governing document, the Charities Act 2011 and the Statement of Recommended Practice, “Accounting and Reporting by Charities”, issued in March 2005.

As shown in the Statement of Accounts, Peaches Womb Cancer Trust’s income for this third year has been predominantly from community fundraising and grants and trusts fundraising. We are very grateful to all of those who chose to donate or fundraise for us and to the organisations who generously gave us grants, particularly GSK, The Basil Samuel Trust and the Marsh Charitable Trust.

For Peaches Womb Cancer Trust to grow and to further its aims and objectives, more human resources in the form of both volunteers and employees is needed. Our primary focus has been, and continues to be obtaining sufficient resources to fund our next employees in a sustainable way. Our secondary financial focus has been to fund a patient support project to create information videos, which are currently in development.

Risk Management

The trustees have assessed the major risks to which the charity is exposed and are satisfied that systems are in place to mitigate exposure to the major risks. An up-todate risk register and review of policies is maintained and regularly reviewed.

Plans for 2024-2025

We asked our community to complete an online survey to help direct our plans and inform our strategic development. We will continue to implement the resulting strategy, incorporating learning from the previous twelve months’ activities. We will be consolidating what has worked well whilst continuing to develop and grow sustainably. We are ambitious for our organisation, our team of staff and volunteers and for the current and future users of our services.

13

Awareness

We will maximise the opportunities afforded to us by awareness months such as Gynaecological Cancer Awareness Month (September 2024) and Womb Cancer Awareness month (June 2025). We will collaborate globally as part of the IGCS campaign. Gynaecological Cancer Awareness Month (September) and Menopause Awareness Month (October)

We will continue to focus on raising awareness of signs and symptoms and the support that we at Peaches are able to provide. We will work towards ensuring that our services are relevant and accessible across communities, looking carefully at our reach and engagement and working with partners to overcome gaps and challenges.

Support

We will extend our information offer through production of a suite of animated videos, supported by Prof. Naveena Singh, a renowned and highly respected gynaecological histopathologist. The videos will be hosted on our website and YouTube channel. We will also look to recruit a part-time, paid Clinical Nurse Specialist to develop our support program with funding already secured from MSD (a pharmaceutical company). We will continue to check in with our supporters and stakeholders, monitoring and evaluating our activities to ensure that they are having the impact and outcomes that we intend to achieve.

Research

We will continue to grow the Peaches Patient Voices community and its involvement in varied research projects, ensuring that womb cancer research is focused on the needs of the patients. We will ensure that our PPV members are supported and included in appraisals and research.

We will invest funds into clinical research, working alongside partners such as Wellbeing of Women. We will continue to offer research bursaries to early career researchers presenting their work into womb cancer at conferences to support the future of womb cancer research. Our long-term goal is to fund significant research projects with tangible outcomes; however, these are very costly. We plan to start a fund that will grow over the coming years to allow us to do this in the future. We will explore ways to fund entry level research posts and collaborate with other organisations.

14

Advocacy

We will continue to advocate for womb cancer patients and their loved ones on a national level to #GiveWombCancerAVoice. We will do everything we can as part of the NICE and SMC appraisal process to ensure that the views of those with experience of womb cancer are counted. We hope that this will increase the likelihood of a positive outcome of these appraisals and approval of these vital new treatments. We will endeavour to continue forming collaborations with strategic organisations and continue activities as a key stakeholder.

Fundraising

We will continue to support and encourage our community fundraisers, building sustainable and long term relationships with individuals, families and teams. We will look to build new partnerships with community groups and the private sector and will facilitate new ways of giving. We will also explore the medium and longer term possibilities offered by grants and trusts as we expand our salaried team and plan activities for the future.

Organisation

Trustees

Over the coming year we will seek to continue to diversify our Board to bring in a wider skillset and different experiences. We will particularly look for Trustees with marketing and fundraising experience. We hope to expand the Board to support the development of our patient support services focusing on the areas not currently covered including oncology and psychological support.

Volunteers

We know the value of volunteers and are grateful for their support as without them we would not be where we are today. We will look for volunteers with marketing, fundraising or patient support experience.

Employees

We will be increasing our paid team to three, with the addition of an employed Clinical Nurse Specialist in early 2025. We will continue to listen to our trustees, staff members and beneficiaries as we implement our strategic plan, ensuring that how we use financial resources on staffing is sustainable and effective.

15

Independent Examiner’s Report

PEACHES WOMB CANCER TRUST INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF PEACHES WOMB CANCER TRUST

I report to the trustees on my examination of the accounts of the charity for the year ended 1 September 2024, which are set out on pages 17 to 20.

Respective responsibilities of trustees and examiner

The charity's trustees are responsible for the preparation of the accounts in accordance with the Charities Act 2011. The charity trustees consider that the audit requirements of section 144 of the Charities Act 2011 do not apply.

It is my responsibility to:

Basis of independent examiner's report

My examination is carried out in accordance with the general directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and seeks explanations from the trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently I do not express an audit opinion on the view given by the accounts.

Independent examiner's statement

In connection with my examination, no matter has come to my attention:

Paul Mellor ACA Clarke Nicklin LLP Chartered Accountants Clarke Nicklin House Cheadle Royal Business Park Cheadle Cheshire SK8 3TD

Dated: 02/04/2025

16

pea￿￿ Womb Cancer Trust STATEMENT OF FINANCIAL ACTIvrrIES (INCLUDING INCOME AND EXPENDrruRE ACCOUNT) FOR THE PERIOD ENDED I SEPTEMBER 2024 Total Fund$ 2024 Total Funds 2023 INCOMING RESOURCES Incomlw resources from gemrated fvnd5 Donations and legacies Income re50urce5 from tharitèble &tivities Bank interest 11.392 49,659 1.342 8,412 56,767 350 Totsl Incornk¥ resources 62.393 32,764 RE%)UR￿$ EXPENDED Cost of generat5ry fvTh15 Costs o18eneraiin8 voluntary income Cost ol producin8 SUPPOrt videos Fundraislng tradin8.' Costs of Boods sold Employee costs Charltable alms 3.425 4.341 2,458 45,902 864 28,030 3,548 54.532 34,037 NEf INCOMING RESOURCES AVAUABLE 7.B61 31,492 Governance costs 8.705 2,$89 Totsl Msour¢•$ exp•n￿d 63,236 36,626 NEf MOVEMENT IN FUNDS 18431 28,903 TOTAL FUNDS CARRIED FORWARD 18431 28.903 17

Peaches Womb Cancer Trust NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED I SEPTEMBER 2024 l ACCOUPItING POLICIES Ba51s of preparatlon The f￿nanCIal statements of the charity. whKh is a public berlitentity under FRS 102. have been prepared in acCOrda￿e with thecharities SORP IFRS 1021'Accounlir arnl Rep(Ktir% byCharitie5'. Ststemenl ol recommended Practlce applicable io charIt￿S prepariry i￿1rac£0UnlS in xcOrda￿e wr£h the Financial ￿e￿rtI￿a ￿andard applicable in the UK and Hepublic ol Ireland IPRS 1021 leflective ljanuary 20151., FinarKial Keportir% Stsr&rd 102.1 he Pinancia REW)rtIr￿ Standard applKablo in tho UK and Ropublic of Irdarxj,. thocharil￿Ac1Ounts Ikotlandl RLyulatlons 2006 and the Charities Act 2011. ThelinarKial statements have been prepared under the historical cost convention. Income All irKomin8 resources are included in the statement ol fvna￿laI ￿1vitE5 when the charity is entitled to the income and the amount can be quantified wlth ￿&sOnable%¢￿ra¢Y. ReMurce• expended Expendlture hès been charged to the Incomeand expenditurea¢¢ouni on theaccnols bals. The Irrecoverableeleme of VAI Is included with item olexpenseto whKh it rdates. Charltsble expendlture comprfses these costs IrKurred by the chadty in the dellvery of its actlvltles and servlces for Its beneficiaries. It irKludes both costs that can be allocatLxl dIr￿llY to such xtivi(ies aTrJ thjsecostsol an Indirect nature necessary to support them. Goveman Direct Lhnatio GIftAid Memory Glvl Legacies 8,499 516 2377 5,927 1.775 709 11,392 8,412 2 INCOMING RESOURCES FORcHARIT￿LE ACTIVITES 2024 202J Owned fundralsi Cornmunity fundrai51 Corporate fundraising Grants and trusts lundraisir Shoppir¥ fundraisi 1,872 34,021 2,713 10,6(N) 454 49,659 6.750 26,033 276 23,460 248 56,767 18

NOTES TO THE FINANCIAL STATEMEMrs FOR THE PERIOD ENDED I SEPTEMBER 2024 3 TOTAL RESOURCES EXPENDED Total 2024 Total 2023 Costs of 8eneratin8 fund5 Costs of generating voluntary income Cost of producin8 SUPPOrt videos Charitable aims Employee tosts Total 3,425 4,341 864 2.458 3.548 28.030 34.037 45,902 54.532 Gov•manc• ¢osts Accountancy ftes Runnin8 Costs 1.134 7,571 8,705 1.140 1,449 2,589 63.236 36.626 4 TRUSTEES None of the trustees lorany per￿n$ tonnetted with theml reteivèd any remuneration during thè perlod. S DEbTOAS 2023 2022 Trade debtors 6 Credltors 2023 2022 Accruals 19

Peaches Womb Cancer Trust BALANCE SHEEr AS AT I SEPTEMBER 2024 2024 2023 Note CURRENT ASSErs Debto Cash and bank 65,758 66,601 65,758 66,601 CREDITORS.. Amounts due wlthln one ￿ar TOTAL ASSETS LESS CURRENT UABILrriES 65,758 66,601 THE FUNOSOFTHE CHARrrY Brought forward funds 66,601 37,694 Movement In year 8431 28,903 Unrestricted lunds 65,758 66.601 TOTAL CHARITY FUNDS 65.758 66.601 20

APPENDIX 1

Background to the charity

In early 2020, a group of doctors from Saint Mary’s Hospital in Manchester, all with research experience and an interest in womb cancer realised that there was no charity dedicated to those affected by womb cancer. They identified that there was a great unmet need for those affected. Womb cancer is the fourth most common cancer in women, affecting nearly 10,000 women every year in the UK and the numbers are rising. However, very few people have heard of womb cancer or know what it is. Additionally, research into womb cancer has long been under-funded compared to other gynaecological cancers such as ovarian and cervical, despite it being more common.

In September 2020, Peaches Womb Cancer Trust was established by Professor Emma Crosbie, Dr Eleanor Jones, Dr Chloe Barr, Dr Helen Clarke, Dr Helena O’Flynn and Mrs Rosemary Pike. Our aim is to improve the lives of those affected by womb cancer by raising awareness, supporting patients, advocating for those affected and promoting and funding research. The name comes from the peach-coloured ribbon that represents womb cancer and was inspired by the fact that a group of those living with womb cancer refer to themselves as “Peach Sisters”.

APPENDIX 2

Biographies of Trustees, staff and key volunteers

Professor Emma Crosbie, President.

Professor Crosbie is Professor of Gynaecological Oncology at the University of Manchester and consultant gynaecological surgeon at St Mary’s Hospital.

Her clinical practice focuses on the surgical and fertility-sparing management of womb cancer and its precursor lesion, atypical hyperplasia. Her research into the prevention and early detection of womb cancer was recognised through a prestigious National Institute for Health and Care Research (NIHR) Clinician Scientist Fellowship award in 2013 and the Royal College of Obstetricians and Gynaecologists William Blair Bell Memorial Lectureship in 2017.

21

She led the James Lind Womb Cancer Alliance Priority Setting Partnership that identified the top ten most important unanswered research questions in womb cancer, according to patients, carers and healthcare professionals. She was Chair of the Endometrial Subgroup of the National Cancer Research Institute (NCRI) Gynaecology Group, Deputy Chair of the NCRI Screening, Prevention and Early Diagnosis (SPED) committee, Prevention and Early Detection Co-Lead for the Manchester NIHR Biomedical Research Centre and Chair of the Research Advisory Committee for the Eve Appeal.

Her research team, Team Womb, has won numerous accolades and awards, including the NCRI Cancer Research Excellence in Surgical Trials (CREST) award in 2019 for outstanding recruitment to surgical trials, the University of Manchester Making A Difference (2021) and PPIE (2021) Awards, the Greater Manchester Cancer Research Award (2022), and the American Association of Cancer Research Team Science Award (2024) and was Highly Commended in the BMJ Cancer Care Team of the Year Awards (2021) for embedding evidence-based Lynch syndrome testing into routine clinical practice.

Dr Helena O’Flynn, Chair of Trustees (September 2023 – August 2024)

Helena is a General Practitioner working in Manchester following the completion of an Academic Clinical Fellowship training programme and a Masters in Public Health.

She has an interest in the early detection of gynaecological cancers in Primary Care and women’s health. She graduated from medical school at the University of Manchester and was subsequently awarded an NIHR Doctoral Research Fellowship in 2018 and has recently completed a PhD at the University of Manchester investigating methods of early detection of endometrial cancer as well as awareness of symptoms of endometrial cancer. She is also the early diagnosis lead for gynaecological cancers at the Greater Manchester Cancer Alliance.

Dr Helen Clarke, Trustee and incoming Chair of Trustees (September 2025)

Dr Clarke is a National Institute of Health Research Academic Clinical Lecturer at the University of Manchester, balancing her research with clinical training in Gynaecological Oncology at St. Mary’s Hospital. She is the Chair of Trustees for 20242025.

Following completion of an undergraduate BSc in Biomedical Science in 2007, she graduated from medical school in 2012. In 2014 she commenced her specialist training in Obstetrics and Gynaecology. She was awarded an £18,000 Wellbeing of

22

Women entry level scholarship for research based at the University of Liverpool in 2016. In 2019 she was awarded a £250,000 clinical research fellowship with Cancer Research UK. Her research focused on a clinical trial evaluating dietary interventions and calorie restriction for the risk reduction of breast and endometrial cancers. She was awarded her PhD in cancer sciences from the University of Manchester in 2023. In 2024 she moved into her current role as an NIHR Academic Clinical Lecturer to continue her research into weight loss and pre-cancer and early endometrial cancer prevention and treatment. She was awarded a Wellbeing of Women-British Gynaecological Cancer Society Post Doctoral Fellowship in December 2024 to fund this research.

Dr Eleanor Jones, Deputy Chair of Trustees

Dr Jones is a Specialist Registrar in Obstetrics and Gynaecology. She undertook her medical training at the University of St Andrews and then the University of Manchester and she began her specialist training in 2015 .

In 2023 she completed her PhD into the early diagnosis of endometrial cancer, under the supervision of Professor Crosbie. Her research focus was the DETECT Study, a large multicentre study which tested a new, less-invasive diagnostic test for endometrial cancer detection. Following on from this, her research has aimed to reduce the burden of invasive investigations on women with postmenopausal bleeding by identifying those who are most likely to have an underlying endometrial cancer.

Sharon Senn, Treasurer (Appointed November 2024)

Sharon qualified as a Chartered Accountant with KPMG in 1986 having trained and worked in North-West offices and Auckland, New Zealand. She moved into Education in 1994, taking on the role at Sir John Deane’s College, Northwich, as Assistant Principal, before becoming the first Bursar and Clerk to the Governors at Withington Girls’ School, Manchester. As a member of the Senior Leadership Team, Sharon took on a broad range of roles including financial management and income generation. Throughout her career, Sharon has supported her local community by leading a lottery application for the High Legh Tennis Club.

23

On retirement from the full-time role in 2021, Sharon maintained her link to Withington Girls’ School by becoming a Trustee of the WGS Trust (a registered charity). She is also a Non-Executive Director (NED) for Edsential Limited, a Community Interest Company, owned by Cheshire West and Chester Council & Wirral Council. The company provides key support services to the Education sector including Catering, Residential courses, Music lessons and holiday courses.

Mr. Simon Burrows, Trustee (Resigned November 2024)

Simon is a chartered accountant, with over 40 years’ experience of working in business – the last 25 years as a CFO in a range of SMOs. His family have been affected by cancer in the past, and he has 2 daughters, and is therefore very committed to the Charity’s ethos and causes. He brings with him huge experience in all areas of finance, corporate governance and financial stewardship – and thus is an invaluable point of reference for the Trustees in the financial management of the Peaches.

Dr Chloe Barr, Trustee

Dr Barr is a subspecialty trainee in gynaecological oncology within the North East Deanery. She was awarded her PhD in 2023 from the University of Manchester.

In 2010, she graduated from the University of Liverpool with MBChB honours and commenced the Obstetrics and Gynaecology specialist training programme in 2013. Her PhD research evaluated novel diagnostic and prognostic biomarkers for gynaecological malignancy.

Debby Nott, Trustee (Appointed November 2024)

Debby is a pharmacist and was diagnosed with womb cancer in 2020, just a few weeks after Peaches Womb Cancer Trust was launched.

Debby has over 30 years’ experience in healthcare. Her career started with a national chain of pharmacies where she developed community-pharmacy led clinical services to support early detection of common health conditions that could be improved or

24

managed with lifestyle changes and medication to help prevent complications from late diagnosis. The latter half of Debby’s career has been spent in the pharmaceutical industry where she led a small team developing the strategies and evidence submissions for health technology assessments to improve patient access for new medicines in the NHS.

Since her diagnosis, Debby has benefitted from the support offered by Peaches Womb Cancer Trust and has been involved in a number of research projects and other patient involvement opportunities through Peaches Patient Voices.

Debby has taken a holistic approach to her own recovery, with a focus on lifestyle changes and emotional wellbeing. She is passionate about empowering others with evidence-based information and accessible tools to improve their health and quality of life.

Mr Malcolm Pike, Trustee

Malcolm joined the board in September 2022. Malcolm is an employment lawyer, business advisor and non-executive director with over 40 years’ experience in private legal practice. He is currently Chair of Governors at Withington Girls’ School, Vice President and NED of the Greater Manchester Chamber of Commerce, Chair of the Rugby Football League’s Independent Employment Tribunal, a member of the ACAS panel of Independent Arbitrators, and Associate General Counsel – Employment (EMEA) at Associated British Foods plc.

Employees

Louise Brimble, CEO (left Peaches October 2024)

Louise was promoted to the position of Peaches CEO in September 2023. She has set the foundations to help Peaches grow in the future by facilitating recruitment, processes and delivering projects as well as coordinating stewardship of fundraisers.

Julia Hewer, Operations Executive (Joined Peaches January 2025)

Julia joins Peaches with a wealth of experience as a charity leader. She comes to Peaches from her CEO role within a Greater Manchester based carers organisation. Relationship building and sustainability, along with excellent, personalised service delivery and efficient processes, are key to Julia and this promises exciting opportunities in the years to come.

25

Julia Benning, Marketing and Communications Manager

Julia joined the team in September 2023 with a solid background in third sector communications and marketing. She hit the ground running, understanding the aspirations of Peaches, and putting internal building blocks in place to set the organisation up for growth. Julia has been responsible for delivering key Peaches campaigns across fundraising and awareness, including “Younger Women Get Womb Cancer Too” during Gynaecological Cancer Awareness Month (Sept 24). Her role supports the dissemination of breakthroughs in womb cancer research, and she works with healthcare professionals to offer trusted patient advice and support via the website and social media.

Julia is currently studying a Master’s degree in Philanthropic Studies at Kent University gaining a high-level understanding of civil society, fundraising, philanthropy, the third sector and volunteering.

Volunteers

Dr Madeline Poulton (left Peaches July 2024)

Madeline is an HR professional with over 20 years’ experience working with regional and global HR teams. She also volunteers for Maternity Action as their HR Volunteer. Madeline joined the Peaches Team in July 2022 and has been pivotal in setting the Charity up as an employer and leading on the recruitment process for our new employee positions within the charity

Anne Lowry, Gynaecological Oncology Clinical Nurse Specialist

Anne is a nurse advisor with the charity, Target Ovarian Cancer. Anne qualified as a nurse and graduated from the University of Northumbria with BSc (Hons) in Nursing Studies in 1997. Anne has always had an interest in womb cancer. She completed her MSc in Nursing Studies in 2019 with distinction and focused the modules of this degree towards learning more about the experiences of women with womb cancer and how best to support them.

Anne has worked within the speciality of gynaecology for most of her career in a variety of roles before becoming a nurse specialist in 2007. The role allowed Anne to support women and their families who are affected by gynaecological cancers. Anne facilitates the Peaches coffee morning group, a monthly virtual support group, which provides a safe space for those affected by womb cancer to share their experiences.

26

Helen White, Peaches Patient Voices

Helen’s experience of womb cancer, combined with her passion for patient and public involvement (PPI), led her to join forces with Peaches in 2021 to establish Peaches Patient Voices, which she now leads.

Helen’s interest in PPI was first sparked when she joined the Participant Panel at Genomics England in 2018, and it grew even further when she became patient representative for the womb cancer research group that analyses data donated by 100,000 Genomes Project participants. Since then, Helen has contributed to a wide range of PPI activities covering prevention, early detection, and treatment of womb cancer. These include her membership of the CanGene-CanVar Patient Reference Panel and the Cancer Research Advocates Forum, UK, formerly known as the NCRI Advocates Forum. Additionally, Helen is a member of the Advisory Committee for the RAINBO trial and serves as a patient expert when new womb cancer treatments are being considered for use in the NHS.

Helen has co-authored a number of publications, is a co-applicant on several research projects, and was awarded a Masters in Research in Public Health in 2022. In 2023, she was appointed Participant Panel Vice Chair for Cancer at Genomics England.

Grace Teeling, Policy and Advocacy

Grace has been living with an advanced cancer diagnosis for the past 5 years. She is a passionate advocate for improving experiences of people living with womb cancer. She supports peaches through being an active member of our Peaches Patient Voice, providing vital contributions to technology appraisals and representing the organisation at events, delivering training and sharing expert lived experience.

Grace has worked across both academia and policy with a focus on energy and water services. She currently works in policy and advocacy for essential services, such as energy affordability. Grace has worked on some varied and interesting roles including community participation in rural wastewater, equality in small town water supplies in Ethiopia.

Harriet Hirst

Harriet began her career as a software developer and is currently a Customer Relationship Manager Leader at Heywood Pension Technologies.

27